mjn-DREAMER
A project to develop a solution for early detection of Alzheimer’s disease
mjn-DREAMER is a project led by mjn-neuro for the development of an early detection solution for Alzheimer's disease.
INNOVATIVE
mjn-DREAMER is a digital solution that combines a cognitive assessment platform with electroencephalographic recording.
- Clinical cognitive biomarkers.
- EEG neurophysiological biomarkers.
- Artificial intelligence algorithm that combines these markers and provides an assessment.
Fast and Reliable
Fully standard
- mjn-DREAMER is a project in regulatory phase for CE marking in Europe.
- It has been developed during 3 years in a CDTI-Misiones project.
- An artificial intelligence algorithm that evaluates the records and classifies them.
mjn-DREAMER FACILITATES SCREENING AND MONITORING OF PATIENTS SUSCEPTIBLE OF SUFFERING SOME COGNITIVE IMPAIRMENT
Features
mjn-DREAMER
- Bluetooth® device with brain activity sensors.
- Connection to tablet via the mjn-DREAMER app.
- Developed for medical professionals.
Contact us
Be the first to find out
Would you like to be informed about the latest news related to the project?